Invention Grant
- Patent Title: Anti-FcRn antibodies
-
Application No.: US16271086Application Date: 2019-02-08
-
Publication No.: US11384148B2Publication Date: 2022-07-12
- Inventor: Helene Margaret Finney , Alastair David Griffiths Lawson , Stevan Graham Shaw , Bryan John Smith , Kerry Louise Tyson , Lara Kevorkian , Christoph Meier , Kaushik Sarkar , Paul Alan Atherfold
- Applicant: UCB Biopharma SPRL
- Applicant Address: BE Brussels
- Assignee: UCB Biopharma SPRL
- Current Assignee: UCB Biopharma SPRL
- Current Assignee Address: BE Brussels
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Doreen Y. Trujillo
- Priority: GB1208370 20120514
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/40 ; C07K16/28 ; G01N33/50 ; G01N33/564 ; G01N33/68 ; A61K47/60 ; A61K47/64 ; C07K16/00 ; A61K39/00
Abstract:
The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.
Public/Granted literature
- US20190248890A1 Anti-FcRn Antibodies Public/Granted day:2019-08-15
Information query
